Diagnosis and manifestations of chronic graft-versus-host disease

Best Practice and Research: Clinical Haematology

Volumn 21, Issue 2, 2008, Pages 251-257

  Filipovich, Alexandra H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

acute GVHD; bronchiolitis obliterans; chronic GVHD; esophageal web; fasciitis; lichen type features; poikiloderma

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DONOR LYMPHOCYTE INFUSION; EARLY DIAGNOSIS; ESOPHAGUS STENOSIS; FASCIITIS; HUMAN; HYPERKERATOSIS; JOINT CONTRACTURE; LABORATORY DIAGNOSIS; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; LUNG BIOPSY; MORPHEA; MYELOABLATIVE CONDITIONING; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; POIKILODERMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REDUCED INTENSITY CONDITIONING; REVIEW; SCORING SYSTEM; SYSTEMIC THERAPY; VAGINA DISEASE;

CHRONIC DISEASE; CONSENSUS DEVELOPMENT CONFERENCES, NIH AS TOPIC; GRAFT VS HOST DISEASE; HUMANS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 44049106681     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2008.02.008     Document Type: Review

References (18)

1. In: Sullivan K.M., Blume K.G., Forman S.J., and Appelbaum F.R. (Eds). Thomas' Hematopoietic Cell Transplantation. 3rd ed. (2004), Blackwell Publishing, Malden, MA 635-664
2. Kim D.H., Jund H.D., Lee N.Y., et al. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and it's severity after allogeneic transplantation. Transplantation 84 (2007) 397-404
3. Shimada M., Onizuka M., Machida S., et al. Association of autoimmune disease-related gene polymorphisms with chronic graft-versus-host disease. British Journal of Haematology 139 (2007) 458-463
4. Sarantopoulos S., Stevenson K.E., Kim H.T., et al. High levels of B-cell activating factor in patients with active chronic graft-versus-host disease. Clinical Cancer Research 15 (2007) 6107-6114
5. Weinberg K., Blazar B.R., Wagner J.E., et al. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97 (2001) 1458-1466
6. Wysoczanska B., Bogunia-Kubik K., Dlubek D., et al. Association with the presence of naïve T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse. Transplant Proceedings 39 (2007) 2898-2901
7. Dutt S., Tseng D., Ermann J., et al. Naïve and memory T cells induce different types of graft-versus-host disease. Journal of Immunology 179 (2007) 6547-6554
8. Przybylski G.K., Kreuzer K.A., Siegert W., et al. No recovery of T-cell receptor excision circles (TRECs) after non-myeloablative allogeneic hematopoietic stem cell transplantation is correlated with the onset of GVHD. Journal of Applied Genetics 48 (2007) 397-404
9. Sullivan K.M., Agura E., Anasetti C., et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Seminars in Hematology 28 (1991) 250-259
10. Przepiorka D., Anderlini P., Saliba R., et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 98 (2001) 1695-1700
11. Lee S.J., Klein J.P., Barrett A.J., et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 100 (2002) 406-414
12. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft vs. host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine 69 (1980) 204-217
13. Kollman C., Howe C.W.S., Anasetti C., et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 98 (2001) 2043-2051
14. Cutler C., Giri S., Jeyapalan S., et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. Journal of Clinical Oncology 19 (2001) 3685-3691
15. Mielcarek M., Martin P.J., Leisenring, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 102 (2003) 756-762
16. Flowers M.E.D., Parker P.M., Johnston L.J., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 100 (2002) 415-419
17. Eapen M., Logan B.R., Confer D.L., et al. Peripheal blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival. Biology of Blood and Marrow Transplantation 13 (2007) 1461-1468
18. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosos and Staging Working Group Report. Biology of Blood and Marrow Transplantation 11 (2005) 945-955